Ivermectin

Ivermectin is an activator linked to PI3K-Akt-mTOR Signaling and Autophagy and related signaling programs and related pathway-oriented research. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to growth-factor signaling, survival control, and nutrient-sensing outputs and autophagic flux, lysosomal turnover, and stress adaptation in autophagy, infectious disease, and neuroscience models.

The pathway annotation connects Ivermectin to PI3K-Akt-mTOR Signaling and Autophagy and related signaling programs, supporting experiments that monitor growth-factor signaling, survival control, and nutrient-sensing outputs and autophagic flux, lysosomal turnover, and stress adaptation across biochemical, cellular, or phenotypic assay formats. This context is compatible with AKT/mTOR readouts, pathway-response, and viability assays and autophagy-flux, lysosome, and cargo-clearance assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In autophagy, infectious disease, and neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling and Autophagy and related signaling programs
• Gain-of-function pathway-activation studies
• Phenotypic profiling in autophagy, infectious disease, and neuroscience models
• Combination studies with orthogonal perturbagens

Overall, Ivermectin is well suited to pathway-oriented studies that need a defined compound input for PI3K-Akt-mTOR Signaling and Autophagy and related signaling programs readouts in autophagy, infectious disease, and neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.